Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4Dr. Reddy's Laboratories

02 12Accord healthcare

03 4Adalvo

04 2Apotex Inc

05 2Auro Pharma Inc

06 1Aurobindo Pharma Limited

07 38Boehringer Ingelheim GmbH

08 4CLONMEL HLTHCARE

09 2Captavis Biocare

10 2Cinfa Laboratories Sa

11 2Cipla

12 2Cipla Medpro South Africa

13 2Dexcel Pharma

14 2Eignapharma S.L.

15 2Eignapharma Sl

16 2Eugia Pharma

17 1Glenmark Pharmaceuticals

18 2HUMANWELL PURACAP PHARMACEUTICALS (WUHAN) CO., LTD

19 2Intas Pharmaceuticals

20 2JAMP PHARMA

21 4Lotus Pharma Bulgaria Eood

22 4Lotus Pharmaceutical

23 4Newbury Pharmaceuticals Ab

24 4Norameda

25 1ORIFARM GROUP AS

26 2Olon S.p.A

27 1Qilu Pharmaceutical

28 2Reddy Pharma Iberia Sa

29 8STADA Arzneimittel

30 10Sandoz B2B

31 10Teva Pharmaceutical Industries

32 4Viatris

33 8Zentiva

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Regulatory Info : RX

Registration Country : USA

NINTEDANIB ESYLATE

Brand Name : NINTEDANIB ESYLATE

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 100MG BASE

Packaging :

Approval Date : 2026-04-02

Application Number : 219283

Regulatory Info : RX

Registration Country : USA

Dr Reddy Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Regulatory Info : RX

Registration Country : USA

NINTEDANIB ESYLATE

Brand Name : NINTEDANIB ESYLATE

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 150MG BASE

Packaging :

Approval Date : 2026-04-02

Application Number : 219283

Regulatory Info : RX

Registration Country : USA

Dr Reddy Company Banner

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Regulatory Info :

Registration Country : India

Nintedanib

Brand Name : Nintedanib

Dosage Form : Oral

Dosage Strength : 100 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Dr Reddy Company Banner

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Regulatory Info :

Registration Country : India

Nintedanib

Brand Name : Nintedanib

Dosage Form : Oral

Dosage Strength : 150 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Dr Reddy Company Banner

05

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

NINTEDANIB

Brand Name : NINTEDANIB

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 100MG BASE

Packaging :

Approval Date :

Application Number : 212732

Regulatory Info :

Registration Country : USA

blank

06

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

NINTEDANIB

Brand Name : NINTEDANIB

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 150MG BASE

Packaging :

Approval Date :

Application Number : 212732

Regulatory Info :

Registration Country : USA

blank

07

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

NINTEDANIB ESYLATE

Brand Name : NINTEDANIB ESYLATE

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 100MG BASE

Packaging :

Approval Date : 2026-04-02

Application Number : 219227

Regulatory Info : RX

Registration Country : USA

blank

08

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

NINTEDANIB ESYLATE

Brand Name : NINTEDANIB ESYLATE

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 150MG BASE

Packaging :

Approval Date : 2026-04-02

Application Number : 219227

Regulatory Info : RX

Registration Country : USA

blank

09

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

NINTEDANIB

Brand Name : NINTEDANIB

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 150MG BASE

Packaging :

Approval Date :

Application Number : 215123

Regulatory Info :

Registration Country : USA

blank

10

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

NINTEDANIB ESYLATE

Brand Name : OFEV

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 100MG BASE

Packaging :

Approval Date : 2014-10-15

Application Number : 205832

Regulatory Info : RX

Registration Country : USA

blank

11

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

NINTEDANIB ESYLATE

Brand Name : OFEV

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 150MG BASE

Packaging :

Approval Date : 2014-10-15

Application Number : 205832

Regulatory Info : RX

Registration Country : USA

blank

12

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

NINTEDANIB ESYLATE

Brand Name : NINTEDANIB ESYLATE

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 100MG BASE

Packaging :

Approval Date : 2026-04-02

Application Number : 212609

Regulatory Info : RX

Registration Country : USA

blank

13

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

NINTEDANIB ESYLATE

Brand Name : NINTEDANIB ESYLATE

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 150MG BASE

Packaging :

Approval Date : 2026-04-02

Application Number : 212609

Regulatory Info : RX

Registration Country : USA

blank

14

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

NINTEDANIB ESYLATE

Brand Name : NINTEDANIB

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 150MG BASE

Packaging :

Approval Date :

Application Number : 212555

Regulatory Info :

Registration Country : USA

blank

15

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

NINTEDANIB ESYLATE

Brand Name : NINTEDANIB ESYLATE

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 100MG BASE

Packaging :

Approval Date : 2026-04-02

Application Number : 216915

Regulatory Info : RX

Registration Country : USA

blank

16

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

NINTEDANIB ESYLATE

Brand Name : NINTEDANIB ESYLATE

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 150MG BASE

Packaging :

Approval Date : 2026-04-02

Application Number : 216915

Regulatory Info : RX

Registration Country : USA

blank

17

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

NINTEDANIB

Brand Name : NINTEDANIB

Dosage Form : CAPSULE

Dosage Strength : 100MG

Packaging :

Approval Date :

Application Number : 219371

Regulatory Info :

Registration Country : USA

blank

18

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

NINTEDANIB

Brand Name : NINTEDANIB

Dosage Form : CAPSULE

Dosage Strength : 25MG

Packaging :

Approval Date :

Application Number : 219371

Regulatory Info :

Registration Country : USA

blank

19

HUMANWELL PURACAP PHARMACEUTICALS (...

Country
AMWC Asia-TDAC
Not Confirmed
arrow

HUMANWELL PURACAP PHARMACEUTICALS (...

Country
arrow
AMWC Asia-TDAC
Not Confirmed

NINTEDANIB

Brand Name : NINTEDANIB

Dosage Form : CAPSULE

Dosage Strength : 100MG

Packaging :

Approval Date :

Application Number : 218472

Regulatory Info :

Registration Country : USA

blank

20

HUMANWELL PURACAP PHARMACEUTICALS (...

Country
AMWC Asia-TDAC
Not Confirmed
arrow

HUMANWELL PURACAP PHARMACEUTICALS (...

Country
arrow
AMWC Asia-TDAC
Not Confirmed

NINTEDANIB

Brand Name : NINTEDANIB

Dosage Form : CAPSULE

Dosage Strength : 25MG

Packaging :

Approval Date :

Application Number : 218472

Regulatory Info :

Registration Country : USA

blank